跳至主要内容
临床试验/ISRCTN22664524
ISRCTN22664524已完成未知

A randomised interventional multicentre trial of ondansetron versus placebo in the treatment of patients with irritable bowel syndrome (IBS) with diarrhoea (IBS-D)

niversity of Nottingham (UK)0 个研究点目标入组 150 人开始时间: 2010年3月31日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Patients with IBS-D meeting the Rome III criteria
  • 2. Patients able to give informed consent
  • 3. Female patients of child bearing potential are willing to use at least one highly effective contraceptive method
  • 4. Aged 18 years and over, either sex

排除标准

  • 1. Women who are pregnant or breast feeding
  • 2. Patients unable to stop anti-diarrhoeal drugs
  • 3. Patients currentluy in, or have been in another clinical trial in the previous 3 months

研究者

发起方
niversity of Nottingham (UK)

相似试验

Ondansetron for the treatment of irritable bowel... | 临床试验